Endoscopic retrograde cholangiopancreatography during pregnancy without radiation

Table 1 Demographic and laboratory results of the patients

Patient number	Age (yr)	WBC/&mgr;L	AST (IU/L)	ALT (IU/L)	GGT (IU/L)	Bilirubin (mg/dL)	Ultrasonography	MRCP
1	32	10.800	61	58	144	1.09	Normal	Fistula presence
11	32	6.690	52	54	136	0.75	Normal	Fistula persistence
2	33	12.000	244	186	324	16.5	Stone in CBD	-
3	27	11.500	126	92	212	10.8	Stone in CBD	-
4	21	14.000	204	144	289	4.85	Stone in CBD	-
5	28	15.200	195	127	326	15.3	Stone in CBD	-
6	29	14.300	262	210	188	8.22	Dilated CBD	Stone in CBD

¹Same patient with repeat ERCP. WBC: White blood cells; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CBD: Common bile duct.

Table 2 Treatment results and obstetric findings

Patient number	Diagnosis	Procedure	CBD content	Gestational time (wk)	Delivery time (wk)
1	Biliary fistula1	Sphincterotomy and scoleces extraction	Scoleces	19
1	Persistent fistula2	Stent placement	-	21	Term
2	Choledocholithiasis	Sphincterotomy and stone extraction	Stone	14	34
3	Choledocholithiasis	Sphincterotomy and stone extraction	Stone	20	36
4	Choledocholithiasis	Sphincterotomy and stone extraction	Multiple stones	34	Term
5	Cholangitis	Sphincterotomy and stone extraction	Impacted stone	28	36
6	Choledocholithiasis	Sphincterotomy and stone extraction	Multiple stones	23	Term

¹After hydatid disease surgery;

²Same patient with repeat ERCP.